Nipro launches ELISIO-HX in the US as expanded hemodialysis targets harder-to-remove toxins
Nipro’s newly FDA-cleared ELISIO-HX is designed to remove larger uremic middle molecules while retaining essential proteins and working with existing hemodialysis infrastructure.
